Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety, tolerability and efficacy of
milnacipran in patients with an inadequate response to duloxetine for the treatment of
fibromyalgia.